Wed, March 2, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Marc Goodman Maintained (AXSM) at Buy with Decreased Target to $50 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Scot Ciccarelli Maintained (AZO) at Strong Buy on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Christopher Horvers Maintained (AZO) at Buy on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Steven Zaccone Maintained (AZO) at Strong Buy on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Simeon Gutman Maintained (AZO) at Hold on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Bobby Griffin Maintained (AZO) at Buy on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Jack Atkins Maintained (ATSG) at Buy with Increased Target to $40 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Matthew O"Brien Maintained (ATEC) at Buy with Decreased Target to $17 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Christine Cho Downgraded (AM) to Sell and Decreased Target to $10 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Matthew Hedberg Maintained (BSY) at Buy with Decreased Target to $55 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Jason Celino Maintained (BSY) at Buy with Decreased Target to $50 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Ricardo Alonso Garcia Upgraded (BSAC) to Buy and Increased Target to $24 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Mark Mahaney Upgraded (BKNG) to Buy on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Mohit Bansal Maintained (BMY) at Hold with Increased Target to $65 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Nick Giovacchini Maintained (ACHC) at Buy with Increased Target to $78 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Travis Steed Initiated (ABT) at Strong Buy and Held Target at $140 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Ivan Feinseth Maintained (ABNB) at Strong Buy with Increased Target to $214 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Aaron Kessler Maintained (ZIP) at Strong Buy with Decreased Target to $41 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Jonathan Chang Maintained (ZLAB) at Buy with Decreased Target to $102 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Jason Wittes Downgraded (ZBH) to Hold and Held Target at $130 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Alex Zukin Downgraded (ZM) to Hold and Decreased Target to $100 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Stephen Bersey Upgraded (ZS) to Strong Buy and Held Target at $296 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Ella Ji Maintained (BIDU) at Strong Buy with Increased Target to $228 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Robert Moskow Maintained (BGS) at Sell with Decreased Target to $26 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Paul Fremont Maintained (ALE) at Hold with Decreased Target to $60 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Michael Binetti Maintained (AKA) at Hold with Decreased Target to $108 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Erinn Murphy Maintained (AKA) at Buy with Decreased Target to $180 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Michael King Maintained (AGEN) at Strong Buy with Increased Target to $280 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Mark Murphy Upgraded (AI) to Hold and Held Target at $27 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Whit Mayo Maintained (AHCO) at Buy with Decreased Target to $24 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Chris Howerton Upgraded (ARDX) to Strong Buy and Increased Target to $5 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Hamed Khorsand Maintained (ARLO) at Strong Buy with Increased Target to $15 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Jeffrey Rand Maintained (ARLO) at Strong Buy with Increased Target to $14 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Adam Tindle Maintained (ARLO) at Buy with Increased Target to $14 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Justin Jenkins Maintained (ARIS) at Buy with Increased Target to $18 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
David Lebowitz Maintained (ARQT) at Buy with Increased Target to $37 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Daniel Imbro Upgraded (ACVA) to Buy and Increased Target to $19 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Ashish Sabadra Maintained (ADT) at Hold with Decreased Target to $9 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Scott Devitt Downgraded (VRM) to Hold and Decreased Target to $320 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
C. Gregory Peters Maintained (VRSK) at Buy with Decreased Target to $220 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Mason Carrico Maintained (VCYT) at Buy with Decreased Target to $44 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Manav Patnaik Upgraded (WSC) to Buy and Increased Target to $50 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Michael Shlisky Maintained (WKHS) at Hold with Decreased Target to $100 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Craig Irwin Upgraded (WKHS) to Strong Buy and Held Target at $140 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
David Begleiter Maintained (WLKP) at Strong Buy with Increased Target to $31 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Ian Macpherson Maintained (WHD) at Hold with Increased Target to $55 on, Mar 2nd, 2022
[ Wed, Mar 02nd 2022 ]: WOPRAI
Matthew Boss Maintained (URBN) at Hold with Increased Target to $32 on, Mar 2nd, 2022

Vikram Purohit Maintained (TBPH) at Sell with Increased Target to $11 on, Mar 2nd, 2022

Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Sell with Increased Target from $10 to $11 on, Mar 2nd, 2022.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 1 agrees with Vikram's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $12 on, Friday, November 5th, 2021


This is the rating of the analyst that currently disagrees with Vikram

  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Thursday, February 24th, 2022